Vildan Yasasever

1.2k citations
53 papers · 957 indexed · h-index 19
Topics
Protease and Inhibitor Mechanisms (9 papers)Peptidase Inhibition and Analysis (8 papers)Angiogenesis and VEGF in Cancer (8 papers)
Partner nations
Türkiye

In The Last Decade

Vildan Yasasever

53 papers receiving 944 citations

Peers

Vildan Yasasever
Comparison fields: 5 of 90
  • Oncology 458
  • Molecular Biology 435
  • Immunology 204
  • Cancer Research 195
  • Pulmonary and Respiratory Medicine 134
Replace Hilal Oğuz with:
Hilal Oğuz Türkiye
Derya Duranyıldız Türkiye
Philipp Manegold United States
Babette Simon Germany
Marco Arndt Germany
Mary Matli United States
David Cervi United States
Aneeta Patel United States
Yun-Fei Xia China
Vildan Yasasever relative to Hilal Oğuz Türkiye Hilal Oğuz's profile →
Citations per field
00.5×1.6×
Hilal Oğuz · 1×
Citations per year

Countries citing papers authored by Vildan Yasasever

Since Specialization
Citations

This map shows the geographic impact of Vildan Yasasever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vildan Yasasever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vildan Yasasever more than expected).

Fields of papers citing papers by Vildan Yasasever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vildan Yasasever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vildan Yasasever. The network helps show where Vildan Yasasever may publish in the future.

Co-authorship network of co-authors of Vildan Yasasever

This figure shows the co-authorship network connecting the top 25 collaborators of Vildan Yasasever. A scholar is included among the top collaborators of Vildan Yasasever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vildan Yasasever. Vildan Yasasever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 5
3 15
4 25
5 8
6 6
7 16
8 32
9 39
10 20
11 50
12
Matriks metalloproteinazlar ve akciğer kanseri
3
13 34
14 2
15 7
16 34
17 21
18 12
19 18
20 6

About Vildan Yasasever

Vildan Yasasever is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 53 papers that have together received 957 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Peptidase Inhibition and Analysis (8 papers) and Angiogenesis and VEGF in Cancer (8 papers). The work is most often cited by research in Oncology (458 citations), Cancer Research (195 citations) and Immunology and Allergy (69 citations). Vildan Yasasever has collaborated with scholars based in Türkiye. Frequent co-authors include Derya Duranyıldız, Hakan Çamlıca, Hilal Oğuz, Erkan Topuz, Faruk Taş, Duygu Derin, Faruk Taş, Neşe Güney, Nejat Dalay and Elif Bilgin. Their work appears in journals such as Journal of Clinical Oncology, Cancer Letters and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026